On 23 March 2020, Leidos Holdings, Inc. (NYSE: LDOS) changed -2.32% to recent value of $70.83. The stock transacted 1493358 shares during most recent day however it has an average volume of 1084.94K shares. It spotted trading -43.71% off 52-week high price. On the other end, the stock has been noted 13.98% away from the low price over the last 52-weeks.

Leidos Holdings, Inc. (LDOS) recently stated financial results for the fourth quarter and fiscal year 2019.

Fiscal Year 2019 Summary Results

Revenues for fiscal year 2019 were $11.09B, contrast to $10.19B in the previous year, reflecting an 8.8% increase.

Operating income for fiscal year 2019 was $912M, contrast to $749M in the previous year. Operating income margin for fiscal year 2019 was 8.2%, contrast to 7.3% in the previous year. Non-GAAP operating margin was 9.9%, contrast to 9.8% in the previous year, primarily Because of the payment of an arbitration award relating to a contract in a previous business operation and favorable program mix.

Diluted EPS attributable to Leidos ordinary stockholders for fiscal year 2019 was $4.60, contrast to $3.80 for the previous year. Non-GAAP diluted EPS for fiscal year 2019 was $5.17, contrast to $4.38 in the previous year. The diluted share count was 145M contrast to 153M in the previous year.

Defense Solutions

Defense Solutions revenues of $5.37B for fiscal year 2019 increased $401M , or 8.1%, contrast to the previous year. The revenue growth was primarily attributable to new awards and a net increase in program volumes, partially offset by the completion of certain contracts.

Defense Solutions operating income margin for fiscal year 2019 was 7.6%, contrast to 7.1% in the previous year. On a non-GAAP basis, operating margin for the year was 8.7% contrast to 8.5% in the previous year, primarily attributable to new awards, the release of a contract reserve and favorable program mix.

Civil

Civil revenues of $3.73B for fiscal year 2019 increased $318M , or 9.3%, contrast to the previous year. The revenue growth was primarily attributable to new awards and a net increase in program volumes, partially offset by the impact of the sale of our commercial cybersecurity business, the completion of certain contracts and lower net profit write-ups in the current year.

Civil operating income margin for fiscal year 2019 was 7.9%, contrast to 8.3% in the previous year. On a non-GAAP basis, operating margin for the year was 10.0%, contrast to 11.2% in the previous year, primarily attributable to lower net profit write-ups in the current year and a net increase in bad debt expense on certain international contracts, partially offset by new awards.

Health

Health revenues of $2.00B for fiscal year 2019 increased $181M , or 10.0%, contrast to the previous year. The revenue growth was primarily attributable to a net increase in program volumes, new awards and our acquisition of IMX, partially offset by the completion of certain contracts and the impact of the sale of our health staff augmentation business.

Health operating income margin for fiscal year 2019 was 12.1%, contrast to 12.7% in the previous year. On a non-GAAP basis, operating margin for the year was 14.3%, contrast to 15.2% in the previous year, primarily attributable to reduced margins on awarded re-compete contracts.

Cash Flow Summary

Net cash provided by operating activities for the quarter were $169M contrast to $104M in the previous year quarter. The higher operating cash inflows were primarily Because of more favorable timing of working capital changes, partially offset by timing of interest payments.

Net cash used in investing activities for the quarter were $54M contrast to $20M in the previous year quarter. The higher cash outflows were primarily Because of higher purchases of property, equipment and software.

Net cash used in financing activities for the quarter were $144M contrast to $290M in the previous year quarter. The decrease in financing cash outflows was primarily Because of lower stock repurchases, partially offset by the timing of dividend and debt payments.

Net cash provided by operating activities for the fiscal year were $992M contrast to $768M in the previous year. The higher operating cash inflows were primarily Because of more favorable timing of working capital changes including higher advance payments from consumers, $59M received in payment of an arbitration award relating to a contract in a previous business operation and lower payments for integration and restructuring costs. These activities were partially offset by higher tax payments, the timing of interest payments and proceeds received from the termination of interest rate swaps in the previous year.

 LDOS has a gross margin of 14.00% and an operating margin of 8.20% while its profit margin remained 6.00% for the last 12 months. Its earnings per share (EPS) expected to touch remained 22.00% for this year while earning per share for the next 5-years is expected to reach at 9.63%.  The company has 144.85M of outstanding shares and 140.61M shares were floated in the market. According to the most recent quarter its current ratio was 1.2 that represents company’s ability to meet its current financial obligations. The price moved ahead of -27.22% from the mean of 20 days, -31.24% from mean of 50 days SMA and performed -21.28% from mean of 200 days price. Company’s performance for the week was -9.19%, -39.58% for month and YTD performance remained -27.64%.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here